Using focused ultrasound to treat anxiety by targeting the anterior thalamus
Magnetic Resonance-guided Focused Ultrasound Ablation of the Anterior Thalamus as a Novel Treatment Paradigm for Anxiety
This study is exploring a new way to help people with anxiety by using a special ultrasound technique to gently target a specific part of the brain, aiming to reduce anxiety symptoms and improve how the brain responds to fear.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-11000833 on NIH RePORTER |
What this research studies
This research investigates a new treatment for anxiety disorders using magnetic resonance imaging-guided focused ultrasound ablation (MRgFUSA). The approach aims to non-invasively target the anterior thalamic nuclei, which are connected to the amygdala, a brain region involved in fear and anxiety. By creating precise lesions in this area, the treatment seeks to reduce exaggerated amygdala reactivity and alleviate anxiety symptoms. Patients will be monitored for changes in their anxiety levels and brain activity throughout the treatment process.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with medication-refractory anxiety disorders who have not responded to conventional treatments.
Not a fit: Patients with anxiety disorders that are well-managed with existing therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a novel, non-invasive treatment option for individuals suffering from anxiety disorders.
How similar studies have performed: While MRgFUSA is a novel approach for treating anxiety, similar techniques have shown promise in treating other neurological conditions, indicating potential for success.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Phan, K. Luan — Ohio State University
- Study coordinator: Phan, K. Luan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.